JDL ACCESS - Key Persons
Job Titles:
- Partner
- Strategic Advisor
Adi is a strategic advisor to medical technology companies, with 25+ years in market access, health economics, and reimbursement strategies. Adi has implemented national strategies to integrate innovations into existing treatment pathways. Adi serves as Industry Representative to the CMS MEDCAC Panel, and is co-Director of the NAMCP New Technologies Executive Leadership Council.
Carla has worked in the fields of Government Affairs and Market Access for over 30 years. She has led reimbursement functions for multi-national companies, as well as for start-ups, including LivaNova, Nevro, AqueSys, and Torax Medical. Her experience in developing and creating teams to remove market access barriers across complex therapies is unique. Carla has an entrepreneurial spirit and, in addition to co-founding JDL Access, she also co-founded JD LYMON and Argenta Advisors.
Chris has been consulting in the medical technology sphere for over 20 years. A statistician by training, his practice focuses on evidence development initiatives to support regulatory and payor needs. He is currently the VP of Evidence Strategy at DuVal and Associates, P.A.
Julie is a seasoned operational leader and has worked within the healthcare and insurance industry for 25+ years. She has experience managing multiple physician practices and has worked at national and regional health plans. Julie has experience launching and operating new business operations and is known for exceeding customer service expectations. She has a Master's degree in Organizational Leadership.
Kim Norton has spent three decades working in medical technology reimbursement, market access, and government affairs. Her career has spanned start-up companies, mid-sized and large device companies, and consulting, providing her with a diverse and comprehensive perspective. Her dedication to helping reimbursement professionals and companies succeed in improving patient access to innovative technologies is the driving force behind her career.
Mark has committed his 25+ year career entirely to the healthcare industry, with the vast majority focused on medical technology, provider reimbursement, and health economics. Mark has extensive experience in payment policy, particularly for new technologies including CMS' New Technology Add-On Payment, Transitional Pass-Through and New Technology APC programs. He has led reimbursement functions for multi-national companies as well as for start-ups and, as a consultant, has helped numerous clients develop and execute reimbursement strategies.